Regen BioPharma, Inc.
Regen BioPharma, Inc.
Your view on RGBP
Overview
What the company does, where it operates, and who runs it.
About Regen BioPharma, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- David Raymond Koos
- Headquarters
- 4700 Spring Street, La Mesa, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- David Raymond Koos
- Headquarters
- 4700 Spring Street, La Mesa, CA, US
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.